Just a day after Pfizer and BioNTech announced the start of trials for their Omicron-specific vaccine booster candidate, Moderna put out word that it too has begun testing an updated vaccine designed to target the variant.
The candidate, dubbed mRNA-1273.529, will be administered to two different cohorts of participants...
